In spite of its ease of operation and good cosmetic acceptance, the Parastep approach has very limited applications for mobility in daily life, because of its modest performance associated with high metabolic cost and cardiovascular strain. However, it can be proposed as a resource to keep physical and psychological fitness in patients with spinal cord injury.
We have investigated physiological changes in 21 patients with a spinal cord injury who were fitted with the RGO-II hybrid orthosis, All parameters were measured before and after a training programme in order to evaluate the benefit of gait rehabilitation, cardiovascular adaptation, constipation, spasticity and osteoporosis_ A tendency for the improvement in cardiovascular function was noticed, and a segmental decrease in right colonic transit time was observed. However there was no reproducible change in spasticity, and no gain in bone mineral density. These data suggest that the physiological benefits which occur when patients walk with the aid of a hybrid orthosis only correct the effects of immobility. In addition, we did not find any physiological improvement regarding the neurological lesion (spasticity or osteoporosis).
The aim of this study was to determine whether the greater ventilation in children at rest and during exercise is related to a greater CO2 ventilatory response. The CO2 ventilatory response was measured in nine prepubertal boys [10.3 years (SD 0.1)] and in 10 adults [24.9 years (SD 0.8)] at rest and during moderate exercise (VCO2 = 20 ml.kg-1.min-1) using the CO2-rebreathing method. Three criteria were measured in all subjects to assess the ventilatory response to CO2: the CO2 sensitivity threshold (Th), which was defined as the value of end tidal PCO2 (PETCO2) where the ventilation increased above its steady-state level; the reactivity slope expressed per unit of body mass (SBM), which was the slope of the linear relation between minute ventilation (VE) and PETCO2 above Th; and the slope of the relationship between the quotient of tidal volume (VT) and inspiration time (tI) and PETCO2 (VT.tI-1.PETCO2(-1)) values above Th. The VE, VT, breathing frequency (fR), oxygen uptake (VO2), and CO2 production (VCO2) were also measured before the CO2-rebreathing test. The following results were obtained. First, children had greater ventilation per unit body weight than adults at rest (P < 0.001) and during exercise (P < 0.01). Second, at rest, only VT.tI-1.PETCO2(-1) was greater in children than in adults (P < 0.001). Third, during exercise, children had a higher SBM (P < 0.02) and VT.tI-1.PETCO2(-1) (P < 0.001) while Th was lower (P < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
Strength ratio between agonist and antagonist muscles provides significant information about muscular equilibrium, which helps to detect musculoskeletal changes and to guide preventive and rehabilitation programs. Isokinetic dynamometry provides reliable values for muscle torque and subsequently on the force ratio between knee flexors and extensors. However, this method is not clinically accessible. A possible alternative to evaluate this force is the One-Repetition Maximum test (One-Rep Max or just 1-RM), which is the most commonly used test for dynamic force assessment. However, there is no report in the literature of the use of 1-RM test for the quantification of knee flexors and extensors ratio. For this reason, the objective of this study was to use the 1-RM test to measure the ratio between knee extensors and flexors in young adults in order to find reference values. The studied sample was composed of 80 young adults (40 men and 40 women), mean age of 22.21 (±3.58) years with no musculoskeletal injuries. They were submitted to the following procedure: IPAQ-short version, weighing and prognostic of 1-RM, warm-up, and unilateral 1-RM test (at the flexor and extensor machine). After the test application, the data were analyzed and the mean values for the ratio between agonist/antagonist found were 52.34% (±9.72) for men and 43.19% (±5.82) for women (which were significantly different between groups). The values found in the present study may be used as reference for asymptomatic individuals with similar age.
The energy cost of walking using a reciprocating gait orthosis (RGOII) with functional electrical stimulation (FES) was assessed in 14 patients with spastic complete paraplegia from six rehabilitation centres. Before and after training asing RGOII with FES, the subjects performed a progressive maximal test on an arm-crank ergometer to obtain their laboratory peak oxygen uptake (LVO2peak), heart rate (HR) and blood lactate concentration changes. At the end of the training session, oxygen uptake (VO2) was measured during a walking test with orthosis at different speeds (6 min steady state at 0.1 m.s-1, followed by 2-min stages at progressively increasing speeds up to exhaustion). Of the subjects 4 repeated this test using orthosis without FES. At a speed of 0.1 m.s-1, VO2 represented 47 (SD 23)% of LVO2peak, mean HR was 137 (SD 21) beats.min-1 and mean blood lactate concentration 2.4. (SD 1.4) mmol.l-1. Maximal speed ranged from 0.23 to 0.5 m.s-1. At maximal speed, VO2 was 91 (SD 18)% of LVO2peak, mean HR reached 96 (SD 7)% and mean blood lactate concentration only 52 (SD 19)% of the maximal values measured during the laboratory test. Walking without electrical stimulation induced an increase in HR but there was no difference in VO2 and blood lactate compared to walking with stimulation. The training period did not result in any improvement in maximal physiological data. We concluded that the free cadence walking speed with orthosis remains much lower than that of able-bodied people or wheelchair users. The metabolic cost at a given speed is much higher even if, using a stimulation device, the cardiovascular stress is reduced.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.